Congress

Politics Rachel Cohrs

STAT Plus: In a showy hearing, Bernie Sanders gets few answers about lower drug prices

The Readout Damian Garde

STAT Plus: Gilead sours on the ‘don’t eat me’ business

D.C. Diagnosis Rachel Cohrs

New pharma CEOs in the hot seat

Politics John Wilkerson

STAT Plus: House panel passes key PBM reform for sliver of commercial market

D.C. Diagnosis Sarah Owermohle

STAT Plus: CDC and social media: The new misinformation war

Politics Rachel Cohrs

STAT Plus: The lone Democrat willing to weaken Medicare’s power to negotiate drug prices

Health Care Inc. Bob Herman

Let the Medicare Advantage lobbying begin

Health tech Lizzy Lawrence

STAT Plus: Medical devices with screens aren’t accessible to the blind. Congress has a chance to change that

Politics Rachel Cohrs

STAT Plus: Senate working group proposes 340B reforms

First Opinion Diana Zuckerman

Medicare has different standards than the FDA. That’s how it should be

D.C. Diagnosis Rachel Cohrs

Medicare drug price negotiation’s day in court

Politics Sarah Owermohle

Congressmen: This Covid hearing ‘could have been an email’

D.C. Diagnosis Sarah Owermohle

The end of an era for the FDA’s longtime drug chief

Politics Sarah Owermohle

STAT Plus: FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next

The Readout Meghana Keshavan

STAT Plus: 23andMe breach targeted Chinese, Jewish populations

Politics Rachel Cohrs

STAT Plus: Merck, Johnson & Johnson CEOs agree to testify in Congress on high drug prices, avoiding Bernie Sanders’ subpoena

First Opinion Ben Hoffman

Congress must pass the child tax credit deal to support kids’ health

Insurance Bob Herman

STAT Plus: Democrats urge government to rein in Medicare Advantage overpayments and denials

Politics Rachel Cohrs

STAT Plus: Merck CEO refused to testify in Senate because he’s not an expert in drug pricing, Bernie Sanders says

Politics Nicholas Florko

STAT Plus: Zyn scrutiny from Sen. Chuck Schumer prompts an unlikely culture war

D.C. Diagnosis Rachel Cohrs

Bernie Sanders’ showdown with pharma CEOs is coming to a head

Politics John Wilkerson

STAT Plus: Key Senate panel considers Medicare bonuses for hospitals that prevent drug shortages

D.C. Diagnosis Sarah Owermohle

STAT Plus: White House pharmacy under the microscope

The Readout Meghana Keshavan

The Senate health committee looks into its first subpoena in 40 years

Politics Rachel Cohrs

Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices

Exclusive Rachel Cohrs

STAT Plus: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension

First Opinion Jeff Goldsmith

The decline and fall of elite multispecialty medical groups

Health Care Inc. Bob Herman

STAT Plus: The state of Medicare Advantage, in one chart

D.C. Diagnosis Sarah Owermohle

STAT Plus: Health care negotiations on Capitol Hill are clear as mud